Portfolio Co Investors 2026 for Bain Capital Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Bain Capital Life Sciences accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $11B. The median disclosed raise is $180M, and the largest is Kymera Therapeutics at $3B, ahead of Kailera Therapeutics ($1.6B) and Imperative Care ($595M).
The names that recur most often on these co-invested cap tables are Bain Capital Life Sciences (33 companies), RA Capital Management (8 companies), Redmile Group (7 companies), BlackRock (5 companies), Janus Henderson Investors (4 companies), Rock Springs Capital (4 companies). By latest disclosed round, the market skews Series A (12), Series C (7), Series B (5), Series D (3).
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide